Masitinib plus FOLFIRI for second-line treatment of metastatic colorectal cancer: 2-year follow-up of phase 2, open label trial
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Masitinib plus FOLFIRI for second-line treatment of metastatic colorectal cancer: 2-year follow-up of phase 2, open label trial |
| Type de publication | Journal Article |
| Year of Publication | 2015 |
| Auteurs | Taieb J., Borg C., Lecomte T., Lepere C., Chatellier T., Smith D., Dubreuil P., Mansfield C., Moussy A., Hermine O. |
| Journal | EUROPEAN JOURNAL OF CANCER |
| Volume | 51 |
| Pagination | S381 |
| Date Published | SEP |
| Type of Article | Meeting Abstract |
| ISSN | 0959-8049 |
| DOI | 10.1016/S0959-8049(16)31066-8 |